Open AccessERCC1 codon 118 polymorphism is a useful prognostic marker in patients with pancreatic cancer treated with platinum-based chemotherapy
Author(s) -
Hirotaka Kamikozuru,
Hidekazu Kuramochi,
Kazuhiko Hayashi,
Go Nakajima,
Masakazu Yamamoto
Publication year - 2008
Publication title -
international journal of oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.405
H-Index - 122
ISSN - 1019-6439
DOI - 10.3892/ijo.32.5.1091
Subject(s) - ercc1 , genotype , cisplatin , medicine , chemotherapy , oncology , pancreatic cancer , biology , allele , gastroenterology , cancer , gene , genetics , dna repair , nucleotide excision repair
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom